{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T13:13:37Z","timestamp":1767964417509,"version":"3.49.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100007375","name":"Pr\u00f3-Reitoria de Pesquisa da Universidade Federal de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007375","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Instituto Nacional de Ci\u00eancia e Tecnologia em Nanobiofarmac\u00eautica"},{"DOI":"10.13039\/501100004901","name":"FAPEMIG","doi-asserted-by":"publisher","award":["PPM-00282-11"],"award-info":[{"award-number":["PPM-00282-11"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"FAPEMIG","doi-asserted-by":"publisher","award":["CBB-APQ-00819-12"],"award-info":[{"award-number":["CBB-APQ-00819-12"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"FAPEMIG","doi-asserted-by":"publisher","award":["CBB-APQ-01778-2014"],"award-info":[{"award-number":["CBB-APQ-01778-2014"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["APQ-482976\/2012-8"],"award-info":[{"award-number":["APQ-482976\/2012-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["APQ-488237\/2013-0"],"award-info":[{"award-number":["APQ-488237\/2013-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["APQ-467640\/2014-9"],"award-info":[{"award-number":["APQ-467640\/2014-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.exppara.2018.02.003","type":"journal-article","created":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T23:45:07Z","timestamp":1518479107000},"page":"24-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Comparing the therapeutic efficacy of different amphotericin B-carrying delivery systems against visceral leishmaniasis"],"prefix":"10.1016","volume":"186","author":[{"given":"D\u00e9bora V.C.","family":"Mendon\u00e7a","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3100-0009","authenticated-orcid":false,"given":"V\u00edvian T.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela P.","family":"Lage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel S.","family":"Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcia A.F.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Maria R.S.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Let\u00edcia T.","family":"Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina K.","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Menezes-Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno M.","family":"Roatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A.P.","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8101-0002","authenticated-orcid":false,"given":"Jos\u00e9 M\u00e1rio","family":"Barichello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana C.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo A.F.","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2018.02.003_bib1","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2015.04.032","article-title":"Recent progress in biomedical applications of Pluronic (PF127): pharmaceutical perspectives","volume":"209","author":"Akash","year":"2015","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.exppara.2018.02.003_bib2","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.exppara.2018.02.003_bib3","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1517\/17425247.2014.932347","article-title":"Mixed formulation of conventional and pegylated liposomes as a novel drug delivery strategy for improved treatment of visceral leishmaniasis","volume":"11","author":"Azevedo","year":"2014","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.exppara.2018.02.003_bib4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1517\/14728214.2012.748036","article-title":"Liposomal amphotericin B as a treatment for human leishmaniasis","volume":"17","author":"Balasegaram","year":"2012","journal-title":"Expet Opin. Emerg. Drugs"},{"key":"10.1016\/j.exppara.2018.02.003_bib5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0378-5173(99)00119-2","article-title":"Absorption of insulin from pluronic F-127 gels following subcutaneous administration in rats","volume":"184","author":"Barichello","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.exppara.2018.02.003_bib6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2217\/nnm.14.116","article-title":"Surface functionalization of polymeric nanospheres modulates macrophage activation: relevance in leishmaniasis therapy","volume":"10","author":"Barros","year":"2015","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.exppara.2018.02.003_bib7","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1128\/IAI.00184-15","article-title":"Genetically modified live attenuated Leishmania donovani parasites induce innate immunity through classical activation of macrophages that direct the Th1 response in mice","volume":"83","author":"Bhattacharya","year":"2015","journal-title":"Infect. Immun."},{"key":"10.1016\/j.exppara.2018.02.003_bib8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fcimb.2012.00069","article-title":"Natural killer cells in experimental and human leishmaniasis","volume":"2","author":"Bogdan","year":"2012","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.exppara.2018.02.003_bib9","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","article-title":"Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection","volume":"71","author":"Coelho","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.exppara.2018.02.003_bib10","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ijantimicag.2012.01.003","article-title":"In\u00a0vitro evaluation of bisnaphthalimidopropyl derivatives loaded into pegylated nanoparticles against Leishmania infantum protozoa","volume":"39","author":"Costa Lima","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.exppara.2018.02.003_bib11","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.nano.2013.12.013","article-title":"Crucial CD8(+) T-lymphocyte cytotoxic role in amphotericin B nanospheres efficacy against experimental visceral leishmaniasis","volume":"10","author":"Costa Lima","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.exppara.2018.02.003_bib12","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1469-0691.2011.03630.x","article-title":"Leishmaniasis chemotherapy: challenges and opportunities","volume":"17","author":"Croft","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.exppara.2018.02.003_bib13","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.4269\/ajtmh.15-0033","article-title":"Efficacy and safety of liposomal amphotericin B for the treatment of mucosal leishmaniasis from the New World: a retrospective study","volume":"93","author":"Cunha","year":"2015","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.exppara.2018.02.003_bib14","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1128\/AAC.01787-15","article-title":"Preclinical studies evaluating subacute toxicity and therapeutic efficacy of LQB-118 in experimental visceral leishmaniasis","volume":"60","author":"Cunha-J\u00fanior","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2018.02.003_bib15","first-page":"117","article-title":"A\u00a0controlled, randomized nonblinded clinical trial to assess the efficacy of amphotericin B deoxycholate as compared to pentamidine for the treatment of antimony unresponsive visceral leishmaniasis cases in Bihar, India","volume":"5","author":"Das","year":"2009","journal-title":"Therapeut. Clin. Risk Manag."},{"key":"10.1016\/j.exppara.2018.02.003_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004087","article-title":"Use of pentamidine as secondary prophylaxis to prevent visceral leishmaniasis relapse in HIV infected patients, the first twelve months of a prospective cohort study","volume":"9","author":"Diro","year":"2015","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.exppara.2018.02.003_bib17","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.parint.2016.07.005","article-title":"Treatment of murine visceral leishmaniasis using an 8-hydroxyquinoline-containing polymeric micelle system","volume":"65","author":"Duarte","year":"2016","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.exppara.2018.02.003_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.exppara.2016.03.026","article-title":"Antileishmanial activity and mechanism of action from a purified fraction of Zingiber officinalis Roscoe against Leishmania amazonensis","volume":"22","author":"Duarte","year":"2016","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2018.02.003_bib19","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.parint.2016.06.009","article-title":"Serial use of pentamidine and miltefosine for treating Leishmania infantum-HIV coinfection","volume":"65","author":"Faucher","year":"2016","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.exppara.2018.02.003_bib20","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1128\/AAC.00639-13","article-title":"Amphiphilic antimony(V) complexes for oral treatment of visceral leishmaniasis","volume":"57","author":"Fernandes","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2018.02.003_bib21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00436-013-3685-8","article-title":"Association of water extract of green propolis and liposomal meglumine antimoniate in the treatment of experimental visceral leishmaniasis","volume":"113","author":"Ferreira","year":"2014","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2018.02.003_bib22","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1517\/17425247.2010.529897","article-title":"New delivery strategies for the old pentavalent antimonial drugs","volume":"7","author":"Fr\u00e9zard","year":"2010","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.exppara.2018.02.003_bib23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.exppara.2018.02.003_bib24","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1021\/mp400603t","article-title":"Covalent functionalized self-assembled lipo-polymerosome bearing amphotericin B for better management of leishmaniasis and its toxicity evaluation","volume":"11","author":"Gupta","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.exppara.2018.02.003_bib25","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1476-5381.2010.01127.x","article-title":"Principles of early drug discovery","volume":"162","author":"Hughes","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.exppara.2018.02.003_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005011","article-title":"Immunotherapeutic potential of eugenol emulsion in experimental visceral leishmaniasis","volume":"10","author":"Islamuddin","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.exppara.2018.02.003_bib27","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1166\/jbn.2012.1414","article-title":"Evaluating the potential of polyester nanoparticles for per oral delivery of amphotericin B in treating visceral leishmaniasis","volume":"8","author":"Italia","year":"2012","journal-title":"J.\u00a0Biomed. Nanotechnol."},{"key":"10.1016\/j.exppara.2018.02.003_bib28","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2174\/15672018113106660057","article-title":"New insights into the diagnosis and chemotherapy for visceral leishmaniasis","volume":"11","author":"Kumar","year":"2014","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.exppara.2018.02.003_bib29","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1007\/s00436-015-4708-4","article-title":"Antileishmanial activity and evaluation of the mechanism of action of strychnobiflavone flavonoid isolated from Strychnos pseudoquina against Leishmania infantum","volume":"114","author":"Lage","year":"2015","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2018.02.003_bib30","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1007\/s00436-016-5181-4","article-title":"An 8-hydroxyquinoline-containing polymeric micelle system is effective for the treatment of murine tegumentary leishmaniasis","volume":"115","author":"Lage","year":"2016","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2018.02.003_bib31","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.pdpdt.2014.10.005","article-title":"Polymeric micelles for enhanced Photofrin II\u00ae delivery, cytotoxicity and pro-apoptotic activity in human breast and ovarian cancer cells","volume":"11","author":"Lamch","year":"2014","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"10.1016\/j.exppara.2018.02.003_bib32","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/cid\/civ416","article-title":"Treatment of disseminated leishmaniasis with liposomal amphotericin B","volume":"61","author":"Machado","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.exppara.2018.02.003_bib33","doi-asserted-by":"crossref","first-page":"e2148","DOI":"10.1371\/journal.pntd.0002148","article-title":"Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasis","volume":"7","author":"Martins","year":"2013","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.exppara.2018.02.003_bib34","article-title":"Antigenicity, immunogenicity and protective efficacy of three proteins expressed in the promastigote and amastigote stages of Leishmania infantum against visceral leishmaniasis","volume":"10","author":"Martins","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.exppara.2018.02.003_bib35","doi-asserted-by":"crossref","first-page":"247","DOI":"10.16943\/ptinsa\/2014\/v80i2\/55105","article-title":"Dynamicity of immune regulation during visceral leishmaniasis","volume":"80","author":"Md","year":"2014","journal-title":"Proc. Indian Natl. Sci. Acad."},{"key":"10.1016\/j.exppara.2018.02.003_bib36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.exppara.2016.07.005","article-title":"Poloxamer 407 (Pluronic\u00ae F127)-based polymeric micelles for amphotericin B: in\u00a0vitro biological activity, toxicity and in\u00a0vivo therapeutic efficacy against murine tegumentary leishmaniasis","volume":"169","author":"Mendon\u00e7a","year":"2016","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2018.02.003_bib37","doi-asserted-by":"crossref","first-page":"e764","DOI":"10.1371\/journal.pntd.0000764","article-title":"A\u00a0curative immune profile one week after treatment of Indian kala-azar patients predicts success with a short-course liposomal amphotericin B therapy","volume":"4","author":"Mondal","year":"2010","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.exppara.2018.02.003_bib38","first-page":"767","article-title":"Evaluation of toxicity and therapeutic efficacy of a new liposomal formulation of amphotericin B in a mouse model","volume":"137","author":"Mishra","year":"2013","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.exppara.2018.02.003_bib39","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.nano.2008.03.007","article-title":"Development, characterization, and toxicity evaluation of amphotericin B-loaded gelatin nanoparticles","volume":"4","author":"Nahar","year":"2008","journal-title":"Nanomedicine"},{"key":"10.1016\/j.exppara.2018.02.003_bib40","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.2147\/IJN.S103344","article-title":"Pluronic\u00ae P123\/F127 mixed micelles delivering Sorafenib and its combination with Verteporfin in cancer cells","volume":"11","author":"Pellosi","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.exppara.2018.02.003_bib41","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ijpharm.2013.07.035","article-title":"Strategies for the design of orally bioavailable antileishmanial treatments","volume":"454","author":"Pham","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.exppara.2018.02.003_bib42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.exppara.2016.02.010","article-title":"Evaluation of the in\u00a0vivo leishmanicidal activity of amphotericin B emulgel: an alternative for the treatment of skin leishmaniasis","volume":"164","author":"Pinheiro","year":"2016","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2018.02.003_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174497","article-title":"To evaluate efficacy and safety of amphotericin B in two different doses in the treatment of post kala-azar dermal leishmaniasis (PKDL)","volume":"12","author":"Rabi Das","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.exppara.2018.02.003_bib44","first-page":"5341","article-title":"An optimized nanoparticle delivery system based on chitosan and chondroitin sulfate molecules reduces the toxicity of amphotericin B and is effective in treating tegumentary leishmaniasis","volume":"9","author":"Ribeiro","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.exppara.2018.02.003_bib45","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1517\/14656566.2013.755515","article-title":"Leishmaniasis: an update of current pharmacotherapy","volume":"14","author":"Sundar","year":"2013","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.exppara.2018.02.003_bib46","doi-asserted-by":"crossref","first-page":"e3169","DOI":"10.1371\/journal.pntd.0003169","article-title":"Efficacy and safety of amphotericin B emulsion versus liposomal formulation in Indian patients with visceral leishmaniasis: a randomized, open-label study","volume":"8","author":"Sundar","year":"2014","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.exppara.2018.02.003_bib47","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1517\/14656566.2015.973850","article-title":"An update on pharmacotherapy for leishmaniasis","volume":"16","author":"Sundar","year":"2015","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.exppara.2018.02.003_bib48","doi-asserted-by":"crossref","first-page":"513","DOI":"10.4269\/ajtmh.14-0259","article-title":"Single-dose indigenous liposomal amphotericin B in the treatment of Indian visceral leishmaniasis: a phase 2 study","volume":"92","author":"Sundar","year":"2015","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.exppara.2018.02.003_bib49","first-page":"98","article-title":"Recent developments and future prospects in the treatment of visceral leishmaniasis","volume":"3","author":"Sundar","year":"2016","journal-title":"Ther. Adv. Infect. Dis."},{"key":"10.1016\/j.exppara.2018.02.003_bib50","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1186\/s12879-016-1746-1","article-title":"Safety and efficacy of liposomal amphotericin B for treatment of complicated visceral leishmaniasis in patients without HIV, North-West Ethiopia","volume":"16","author":"Tamiru","year":"2016","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.exppara.2018.02.003_bib51","first-page":"1","article-title":"Chemotherapy of leishmaniasis: present challenges","volume":"20","author":"Uliana","year":"2017","journal-title":"Parasitology"},{"key":"10.1016\/j.exppara.2018.02.003_bib52","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1007\/s11095-008-9588-1","article-title":"Combination antifungal therapy involving amphotericin B, rapamycin and 5-fluorocytosine using PEG-phospholipid micelles","volume":"25","author":"Vakil","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.exppara.2018.02.003_bib53","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.parint.2011.06.001","article-title":"Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species","volume":"60","author":"Valadares","year":"2011","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.exppara.2018.02.003_bib54","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.exppara.2012.07.005","article-title":"Prophylactic or therapeutic administration of Agaricus blazei Murill is effective in treatment of murine visceral leishmaniasis","volume":"132","author":"Valadares","year":"2012","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2018.02.003_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004495","article-title":"Treatment of cutaneous leishmaniasis caused by Leishmania aethiopica: a systematic review","volume":"10","author":"Van Griensven","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.exppara.2018.02.003_bib56","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijpharm.2006.12.033","article-title":"Difunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines","volume":"337","author":"Wang","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.exppara.2018.02.003_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004880","article-title":"Efficacy and safety of ambisome in combination with sodium stibogluconate or miltefosine and miltefosine monotherapy for african visceral leishmaniasis: phase II randomized trial","volume":"10","author":"Wasunna","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.exppara.2018.02.003_bib58","author":"World Health Organization"},{"key":"10.1016\/j.exppara.2018.02.003_bib59","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1016\/j.biomaterials.2010.12.039","article-title":"Multifunctional Pluronic P123\/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumors","volume":"32","author":"Zhang","year":"2011","journal-title":"Biomaterials"}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489417303077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489417303077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T23:53:07Z","timestamp":1535068387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489417303077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":59,"alternative-id":["S0014489417303077"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2018.02.003","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing the therapeutic efficacy of different amphotericin B-carrying delivery systems against visceral leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2018.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}